James L. Gulley, MD, PhD of National Cancer Institute at the National Institutes of Health gives an overview of the new and upcoming trends of 2017 for immunotherapy. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.